ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
Janssen
['cartitude', 'cartitude-4', 'multiple myeloma']
#eha2023 i prof. michel delforge from , provided an excellent overview of the current state of multiple myeloma. he also shed light on the near future by discussing the first phase 3 results from the cartitude-4 study 
MediMix, your communication partner with a focus on quality information in easy consumable formats, tailor-made for medical specialists.